Skip to content

Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery

Individualized Brain Stimulation to Improve Functional Rehabilitation in Two Models of Sensorimotor Disorders: Stroke and Parkinson's Disease

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05220449
Acronym
R4V
Enrollment
30
Registered
2022-02-02
Start date
2017-09-01
Completion date
2025-12-31
Last updated
2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease, Stroke, Visual Impairment

Keywords

Stroke, Visual field, Oscillations, tACS, Parkinson's Disease

Brief summary

This project assesses the effect of bifocal cross-frequency transcranial alternating current stimulation (tACS) combined with visual training to improve visual recovery and orchestrated oscillatory activity in stroke patients suffering from visual field defects.

Interventions

OTHERCross-frequency dual-site tACS

Dual site transcranial alternating current stimulation over the primary visual cortex (V1) and the mediotemporal cortex (MT/V5) using two different stimulation frequencies (Alpha and Gamma)

Sponsors

Ecole Polytechnique Fédérale de Lausanne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Double (Participant & Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. the patient can consent for themselves; 2. age 18+ years old; 3. at least 7 days since diagnosis stroke. 4. Patients should demonstrate a clear deficit in either simple or complex visual perception in portions of their visual field

Exclusion criteria

1. Diminished capacity to consent; 2. Pregnancy 3. Known or suspected non-compliance, drug or alcohol abuse 4. Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant, 5. Non-compliance to the instructions of the experimenter or an inappropriate behavior hindering the normal progress of the experiment. 6. Previous enrolment into the current study 7.

Design outcomes

Primary

MeasureTime frameDescription
Changes in visual field functionsMeasured at baseline (i.e. before the first day of intervention), and post intervention (i.e., after the last day of intervention)Comparison of the systematic measurement of the visual field using Humphrey perimetry

Secondary

MeasureTime frameDescription
Changes in motion discrimination and integration performancesMeasured at baseline (i.e. before the first day of intervention), and post intervention (i.e., after the last day of intervention)Comparison of the motion coherence threshold extracted from a two forced-choice direction discrimination task
Changes in inter-areal cross-frequency interactionMeasured at baseline (i.e. before the first day of intervention), and post intervention (i.e., after the last day of intervention)Comparison of the inter-areal Alpha-Gamma coupling using electroencephalography recordings
Changes in visual tracts integrityMeasured at baseline (i.e. before the first day of intervention), and post intervention (i.e., after the last day of intervention)Comparison of the diffusion weigted imaging-based tractography of the main visual tracts
Changes in functional connectivity within the broad visual networkMeasured at baseline (i.e. before the first day of intervention), and post intervention (i.e., after the last day of intervention)Functional MRI based connectivity analyses using DCM or graph theory will perfomed

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026